FL CARES: Cancer Drug Property Dataset

Brand Name:
Code(s): ONT-380
Approved:
Kinase Class: RY
Inhibitor Type: I ½ B
Literature (PubMed): <a href="https://pubchem.ncbi.nlm.nih.gov/compound/#section=Literature" target="_blank"> 0
Target(s): Erb-b2 receptor tyrosine kinase 2
Disease(s): Her2-receptor positive breast cancer

Tucatinib US FDA Label

Compound: 6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine
Description: NA

International Nonproprietary Name: Tucatinib [INN] (Source: PubChem)

KEGG Drug ID: D11141 (Source: PubChem)

USFDA Precision ID: UNII-234248D0HH (Source: PubChem)

US Adopted Name: TUCATINIB [USAN] (Source: PubChem)

Sources: PubChem (4)